Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 4, 2010, Pages 529-534

  Spaander, M C W ^a   Van Buuren, H R ^a   Hansen, B E ^a   Janssen, H L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN; MYELOPROLIFERATIVE DISORDER; OVERALL SURVIVAL; PARTIAL THROMBOPLASTIN TIME; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPLENIC VEIN; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASCITES; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PORTAL VEIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 77954726643     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04375.x     Document Type: Article

References (21)

1. Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther 2010 31:366 374.
2. Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005 41:603 608.
3. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000 96:2364 2368.
4. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000 31:587 591.
5. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999 353:1167 1173.
6. Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther 2009 30:881 894.
7. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987 7:122 128.
8. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004 39:841 856.
9. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001 120:726 748.
10. Leiva JG, Salgado JM, Estradas J, Torre A, Uribe M. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents. Ann Hepatol 2007 6:214 221.
11. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005 43:167 176.
12. Rangari M, Gupta R, Jain M, Malhotra V, Sarin SK. Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int 2003 23:434 439.
13. Kuiper JJ, de Man RA, van Buuren HR. Review article: management of ascites and associated complications in patients with cirrhosis. Aliment Pharmacol Ther 2007 26 (Suppl. 2 183 193.
14. Salerno F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993 88:514 519.
15. Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med 2001 345:1683 1688.
16. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009 49:1729 1764.
17. Janssen HL, Wijnhoud A, Haagsma EB, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001 49:720 724.
18. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001 120:490 497.
19. Spaander MC, Murad SD, van Buuren HR, Hansen BE, Kuipers EJ, Janssen HL. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointest Endosc 2008 67:821 827.
20. Vleggaar FP, van Buuren HR, Schalm SW. Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population. Eur J Gastroenterol Hepatol 1998 10:81 5.
21. Spaander VM, van Buuren HR, Janssen HL. Review article: the management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults. Aliment Pharmacol Ther 2007 26 (Suppl. 2 203 209.